SEC Info - Therapy Cells Inc - ‘10-K’ for 12/31/11

SEC Info℠

Home

Help

Please Sign In

Therapy Cells Inc – ‘10-K’ for 12/31/11 – ‘EX-32.1’

On: Friday, 10/11/19, at 5:02pm ET · For: 12/31/11 · Accession #: 1683168-19-3240 · File #: 333-149978

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/11/19  Therapy Cells Inc                 10-K       12/31/11    3:367K                                   GlobalOne Filings Inc/FA

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    231K 
 2: EX-31.1     Certification of Chief Financial Officer            HTML     10K 
 3: EX-32.1     Certification of Chief Executive Officer and Chief  HTML      6K 
                Financial Officer

‘EX-32.1’ — Certification of Chief Executive Officer and Chief Financial Officer

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Paul Knudson, the Chief Executive Officer and Chief Financial Officer of Therapy Cells Inc. (formerly known as Diamond Information Institute Inc., hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to their knowledge, the Form 10-K of Therapy Cells, Inc., fka Diamond Information Institute Inc. for the fiscal year ended December 31, 2011, except for auditing, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Annual report of Form 10-K fairly presents in all material respects the financial condition and results of operations of Therapy Cells, Inc., fka Diamond Information Institute Inc.

Date: October 11, 2019

/s/ “Paul Knudson”

Paul Knudson

Chief Executive Officer

/s/ “Paul Knudson”

Paul Knudson

Chief Financial Officer, Principal Accounting Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this statement required by Section 906, has been provided to Diamond Information Institute Inc. and will be retained by Diamond Information Institute Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-K’ Filing	Date	Other Filings

Filed on:	10/11/19	10-Q
For Period end:	12/31/11
		List all Filings

↑Top

Filing Submission 0001683168-19-003240 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)